IGF-1 LR3
Long-acting insulin-like growth factor for anabolic research
Modified IGF-1 with reduced binding to IGF binding proteins, extending half-life. Research investigates anabolic and metabolic effects. For research purposes only.
Activates IGF-1 receptors with extended duration, promoting protein synthesis and cell growth
This peptide has been extensively studied in research settings. Our team stays current with the latest peer-reviewed research to provide evidence-based recommendations during your consultation.
Research Areas:
- • Clinical efficacy and safety profiles
- • Optimal dosing protocols and administration
- • Synergistic effects with other compounds
- • Long-term outcomes and sustainability
Storage Requirements
Certificate of Analysis (COA)
Each batch includes a COA verifying ≥98% purity through independent third-party testing.
Free 15-minute discovery call to discuss your optimization goals
Personalized dosing protocols based on your unique biology and goals
Safety screening and contraindication assessment
Ongoing support and protocol optimization
Access to exclusive patient resources and dosing guidelines
These products are intended for research purposes only. Not for human consumption. Consult with a qualified healthcare professional before use.